Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Miglitol. Always confirm against the full prescribing information.
100 interactions
Acarbose
The risk or severity of hypoglycemia can be increased when Acarbose is combined with Miglitol.
Level 2 evidence
Acebutolol
The therapeutic efficacy of Miglitol can be increased when used in combination with Acebutolol.
Level 1 evidence
Acetylsalicylic acid
The risk or severity of hypoglycemia can be increased when Acetylsalicylic acid is combined with Miglitol.
Level 1 evidence
Alclometasone
The risk or severity of hyperglycemia can be increased when Alclometasone is combined with Miglitol.
Level 1 evidence
Alogliptin
The risk or severity of hypoglycemia can be increased when Miglitol is combined with Alogliptin.
Level 2 evidence
Amcinonide
The risk or severity of hyperglycemia can be increased when Amcinonide is combined with Miglitol.
Level 1 evidence
Aminosalicylic acid
Aminosalicylic acid may increase the hypoglycemic activities of Miglitol.
Level 2 evidence
Amiodarone
The risk or severity of hypoglycemia can be increased when Amiodarone is combined with Miglitol.
Level 2 evidence
Amitriptyline
Amitriptyline may decrease the hypoglycemic activities of Miglitol.
Level 2 evidence
Amlodipine
The risk or severity of hypoglycemia can be increased when Amlodipine is combined with Miglitol.
Level 2 evidence
Amoxapine
Amoxapine may decrease the hypoglycemic activities of Miglitol.
Level 2 evidence
Aripiprazole
The therapeutic efficacy of Miglitol can be decreased when used in combination with Aripiprazole.
Miglitol has 299 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Miglitol has 0 major, 260 moderate, and 39 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Miglitol. Always confirm against the full prescribing information.